4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-016931
President and CEO sold 18,333 shares at an average $22.18 ($406,601)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2019-03-01 | Sale | −4,000 | $22.19 | $88,760 | 2,630,304 | I |
| Watts Ryan J. President and CEO | 2019-03-01 | Sale | −2,050 | $22.91 | $46,966 | 2,628,254 | I |
| Watts Ryan J. President and CEO | 2019-03-04 | Sale | −4,442 | $21.87 | $97,147 | 2,623,812 | I |
| Watts Ryan J. President and CEO | 2019-03-04 | Sale | −1,700 | $22.83 | $38,811 | 2,622,112 | I |
| Watts Ryan J. President and CEO | 2019-03-05 | Sale | −6,141 | $21.97 | $134,918 | 2,615,971 | I |
| Open-market sales · 18,333 sh · avg $22.18 · $406,601 | |||||||
Loading xslF345X03/doc4.xml…